Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Total Current Liabilities (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 7 years of Total Current Liabilities data on record, last reported at $877000.0 in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 25.29% year-over-year to $877000.0; the TTM value through Sep 2025 reached $877000.0, up 25.29%, while the annual FY2024 figure was $725000.0, 65.24% down from the prior year.
  • Total Current Liabilities reached $877000.0 in Q3 2025 per CYCN's latest filing, up from $800000.0 in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $13.5 million in Q1 2021 and bottomed at $700000.0 in Q3 2024.
  • Average Total Current Liabilities over 5 years is $5.6 million, with a median of $4.9 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: crashed 80.87% in 2024, then grew 25.29% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $11.1 million in 2021, then tumbled by 31.2% to $7.6 million in 2022, then crashed by 72.65% to $2.1 million in 2023, then tumbled by 65.24% to $725000.0 in 2024, then increased by 20.97% to $877000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $877000.0 in Q3 2025, $800000.0 in Q2 2025, and $1.1 million in Q1 2025.